Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Broadly yes
The 2026 Prohibited List took effect on 1 January 2026
Compound identity at a glance Name: Retatrutide INN: LY3437943 Class: Triple incretin receptor agonist Structure: 39-amino-acid synthetic peptide Dosing interval: Once weekly (research protocols) Developer: Eli Lilly For the full molecular reference (molecular formula, molecular weight, CAS number and the 39-amino-acid sequence) see the Retatrutide molecular profile
Figure 4, Panel D, presents a forest plot of HRs for non-fatal MI, illustrating a numerically lower point estimate for tirzepatide compared to the GLP-1RA class
Inform your doctor if you have active stomach ulcers, high blood pressure, or any associated problems
Ozempic and Wegovy contain the same active ingredient (semaglutide) but are FDA-approved for different uses
